C Richard Conti. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdultAnticoagulants/therapeutic useFemaleFibrinolytic Agents/administration & dosageHeart Valve Diseases/drug therapyHeart Valve Diseases/etiologyHeart Valve Diseases/surgeryHeart Valve Prosthesis Implantation/adverse effectsHematologic Agents/administration & dosageHeparin/administration & dosageHumansPregnancyPregnancy Complications, Cardiovascular/drug therapyThrombolytic TherapyThrombosis/drug therapyThrombosis/etiologyTissue Plasminogen Activator/administration & dosageWarfarin/therapeutic use
Substances: See more » AnticoagulantsFibrinolytic AgentsHematologic AgentsWarfarinHeparinTissue Plasminogen Activator
Year: 2006 PMID: 16881534 PMCID: PMC6654566 DOI: 10.1002/clc.4960290702
Source DB: PubMed Journal: Clin Cardiol ISSN: 0160-9289 Impact factor: 2.882